Search

everythinglearnresearchcommunity

for

Search:↓

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

C.I. Acid Orange 3 caused cancer in female rats but not in male rats or mice.

Acetyl tetrapeptide-3 was successfully made for use in hair loss treatments.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Thyroid hormone (T3) may reverse gray hair by stimulating hair growth.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

A mutation in the hHb3 gene is linked to the hair disorder monilethrix.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

TURP specimens should be checked for various tumors, not just common prostate issues.

Thorough evaluation and treatment are crucial for thyroid nodules.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

A man with a skin nodule was diagnosed with a rare skin condition called cutaneous focal mucinosis, which can be confused with other skin cancers.